As CEO of Marengo Therapeutics and a director of the company’s board, Zhen Su brings nearly three decades of experience as a physician-scientist and biopharma executive, with expertise …

Zhen Su. Central China Normal University. ... Z Su, J Chen, J Stansby, C Jia, T Zhao, J Tang, Y Fang, A Rawal, J Ho, ... Small 18 (22), 2201449, 2022. 51: 2022: Cooperative boron and …

YX Xue, J Zhang, Z Su, Y Wu, Q Liang, MQ Liang, XZ Liu, CJ Chen, ... 2022 IEEE/ACM International Conference on Advances in Social Networks … Source of rainfall above …

Currently, Dr. Su serves as the Chief Executive Officer of Marengo Therapeutics and member of its Board of Directors, having held both positions since July 2021. Prior to joining Marengo, Dr. …

Zhen Su's 22 research works with 116 citations, including: Ambient Temperature Bacterial Large Ribosomal Subunit Structure Enabled by Serial Femtosecond X-ray Crystallography

2024年12月9日 · Zhen Su, CEO at Marengo Therapeutics, shared a post on LinkedIn: “Overcome PD-1 resistant in solid tumor with a novel dual T-cell agonist approach. We are presenting our …

Zhen Su (Member, IEEE) was born in Hebei, China. She received the B.Sc. degree from Shandong University, Jinan, China, in 2011, the M.Sc. degree from The Hong Kong University …

Zhen Su via Europe PubMed Central A systemic identification approach for primary transcription start site of Arabidopsis miRNAs from multidimensional omics data. Functional & integrative …

Zhen Su, MD, MBA Director. Dr. Su has served as a member of our Board of Directors since August 2023. Dr. Su has been the Chief Executive Officer of Marengo Therapeutics and …